Miriam Merad, MD, PhD

@MiriamMerad · Manhattan, NY · joined 16 Nov 2016

Director, Immunology Institute @SinaiImmunol @IcahnMountSinai | Harnessing the innate immune system for novel therapies against cancer & inflammatory diseases.

17 235Followers

473Following

1 510Posts total

133.6KViews on collected posts

Derniers posts

Miriam Merad, MD, PhD@MiriamMerad10 Aug

In this article, I argue that pandemics, antimicrobial resistance, cancer, inflammatory diseases & aging are among the greatest threats to our societies. Yet biomedical research receives a fraction of military spending, when in fact the #NIH is also a “Department of Defense”. 7.7K views · 56 likes · 10 reposts · 2 replies Open on X →

Miriam Merad, MD, PhD@MiriamMerad9 Aug

I enjoyed contributing to this @nytimes piece on the role of macrophages in driving inflammation, how chronic inflammation contributes to many major human diseases, and the growing potential of targeting inflammation to prevent and treat disease. @SinaiImmunol #Inflammation 14K views · 106 likes · 9 reposts · 1 replies Open on X →

Miriam Merad, MD, PhD@MiriamMerad3 Aug

How does chronic inflammation shape our risk for cancer & other diseases as we age? 🔬 Great piece in the @nytimes exploring the latest science, including insights from @MiriamMerad, who was recently awarded funding by @TheMarkFdn, @WaxmanCancer, & @AmericanCancer to study 12.6K views · 15 likes · 3 reposts · 0 replies Open on X →

Miriam Merad, MD, PhD@MiriamMerad20 Jul

Very pleased to share this new commentary on the extraordinary biology of resident tissue macrophages (RTMs). RTMs are the most evolutionarily conserved immune cells. They emerged before adaptive immunity and blood circualtion (1/4) https://t.co/9t0FmXz3jt 20.2K views · 179 likes · 37 reposts · 2 replies Open on X →

Miriam Merad, MD, PhD@MiriamMerad18 Jul

Beautiful study showing that aging leads to resident tissue macrophages (RTM) decline in number and function. EP2 deletion restores RTM phagocytic capacity and clearance of senescent neutrophils, reduces chronic inflammation, and improves cognition, muscle & cardiac function 1/2 13.8K views · 93 likes · 5 reposts · 2 replies Open on X →

Miriam Merad, MD, PhD@MiriamMerad17 Jul

Macrophages are constitutive architects of tissue integrity https://t.co/QG4QCjUJV6 27.5K views · 86 likes · 33 reposts · 0 replies Open on X →

Miriam Merad, MD, PhD@MiriamMerad16 Jul

@MiriamMerad @ScienceMagazine @jboumelha @SinaiImmunol Many congratulations Dr. Merad and team!! What an elegant and impactful study!! 🎉👏🏻 487 views · 2 likes · 0 reposts · 0 replies Open on X →

Miriam Merad, MD, PhD@MiriamMerad16 Jul

Many thanks to our colleagues for their intellectual insights, collaboration and generosity @NikJoshi @KamphorstAlice @BcellBruno @HeleneSalmon - It was a pleasure working with you all. 1.9K views · 13 likes · 0 reposts · 0 replies Open on X →

Miriam Merad, MD, PhD@MiriamMerad16 Jul

Excited to share our new study @ScienceMagazine by the fantastic Raphael Mattiuz and @jboumelha @SinaiImmunol showing how DC build and sustain tertiary lymphoid structures in cancer. A major step toward enhancing anti-tumor immunity (1/2) https://t.co/H8awCDz0HM https://t.co/ByN

35.3K views · 370 likes · 99 reposts · 14 replies Open on X →

Face aux comptes de taille comparable

3 posts des 90 derniers jours, à côté de la tranche de 10K–100K abonnés. diffusé largement, mais peu de ces spectateurs réagissent.

Vues médianes12 577ce compte924médiane pour 10K–100K

Portée, %72.97%ce compte3.62%médiane pour 10K–100K

Engagement, %0.83%ce compte1.52%médiane pour 10K–100K

Indicateur	Ce compte	Médiane pour 10K–100K	Rapport
Vues médianes par post	12 577	924	13.6×
Portée (vues ÷ abonnés)	72.97%	3.62%	20.2×
Taux d'engagement	0.83%	1.52%	0.54×

Autres comptes de cette tranche → Comparer avec un autre compte → Comment ces repères sont établis →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

35.3K16 Jul

1.9K

487

27.5K17 Jul

13.8K18 Jul

20.2K20 Jul

12.6K3 Aug

14K9 Aug

7.7K10 Aug

Last 9 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.37%16 Jul

0.67%

0.41%

0.43%17 Jul

0.72%18 Jul

1.08%20 Jul

0.14%3 Aug

0.83%9 Aug

0.88%10 Aug

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes68.2%920 in total

Reposts14.5%196 in total

Replies1.6%21 in total

Bookmarks15.7%212 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Derniers posts

Face aux comptes de taille comparable

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Comptes similaires